US Pain management devices Market

ID: MRFR/MED/11736-CR
100 Pages
Nidhi Mandole
Last Updated: April 24, 2026
US Pain Management Devices Market Research Report: Size, Share, Trend Analysis By Type (stimulators, transcutaneous Electrical Nerve Stimulation Devices, Pumps, Ablation Devices), Application (Cancer Pain, Musculoskeletal Pain, Migraine and Other)) - Growth Outlook & Industry Forecast 2025 To 2035
US Pain management devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.84%
2024 Market Size$ 1,609.7 Million
2025 Market Size$ 1,719.8 Million
2035 Market Size$ 3,332.53 Million
Key Players
Medtronic
Boston Scientific
Abbott Laboratories
Johnson & Johnson
Stryker Corporation
NeuroMetrix
Trends
  • Technological Advancements
  • Patient-Centric Approaches
  • Regulatory Changes
Opportunities
  • Rising Prevalence of Chronic Pain
  • Technological Innovations in Device Design
  • Aging Population and Associated Pain Conditions
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Device Type (USD Million)
      1. 4.1.1 Stimulators
      2. 4.1.2 Analgesics Delivery Devices
      3. 4.1.3 Cryotherapy Devices
      4. 4.1.4 Radiofrequency Ablation Devices
    2. 4.2 Pharmaceutical, BY Therapeutic Area (USD Million)
      1. 4.2.1 Chronic Pain
      2. 4.2.2 Acute Pain
      3. 4.2.3 Postoperative Pain
      4. 4.2.4 Cancer Pain
    3. 4.3 Pharmaceutical, BY End User (USD Million)
      1. 4.3.1 Hospitals
      2. 4.3.2 Home Care Settings
      3. 4.3.3 Ambulatory Surgical Centers
      4. 4.3.4 Physical Therapy Clinics
    4. 4.4 Pharmaceutical, BY Technology (USD Million)
      1. 4.4.1 Transcutaneous Electrical Nerve Stimulator
      2. 4.4.2 Intrathecal Drug Delivery Systems
      3. 4.4.3 Cryoablation Technology
      4. 4.4.4 Radiofrequency Technology
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Medtronic (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Abbott Laboratories (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Johnson & Johnson (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Stryker Corporation (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 NeuroMetrix (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Halyard Health (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Cymedica Orthopedics (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY DEVICE TYPE
    3. 6.3 US MARKET ANALYSIS BY THERAPEUTIC AREA
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY TECHNOLOGY
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY DEVICE TYPE, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY DEVICE TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY THERAPEUTIC AREA, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY TECHNOLOGY, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DEVICE TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY TECHNOLOGY, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Pain management devices Market Segmentation

US Pain management devices Market By Device Type (USD Million, 2025-2035)

  • Stimulators
  • Analgesics Delivery Devices
  • Cryotherapy Devices
  • Radiofrequency Ablation Devices

US Pain management devices Market By Therapeutic Area (USD Million, 2025-2035)

  • Chronic Pain
  • Acute Pain
  • Postoperative Pain
  • Cancer Pain

US Pain management devices Market By End User (USD Million, 2025-2035)

  • Hospitals
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Physical Therapy Clinics

US Pain management devices Market By Technology (USD Million, 2025-2035)

  • Transcutaneous Electrical Nerve Stimulator
  • Intrathecal Drug Delivery Systems
  • Cryoablation Technology
  • Radiofrequency Technology

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.